Published in Genet Med on March 01, 2011
Exome sequencing as a tool for Mendelian disease gene discovery. Nat Rev Genet (2011) 14.29
Clinical interpretation and implications of whole-genome sequencing. JAMA (2014) 7.24
Rapid whole-genome sequencing for genetic disease diagnosis in neonatal intensive care units. Sci Transl Med (2012) 5.16
Implementing genomic medicine in the clinic: the future is here. Genet Med (2013) 4.89
Whole-genome sequencing for optimized patient management. Sci Transl Med (2011) 4.51
An informatics approach to analyzing the incidentalome. Genet Med (2012) 4.31
Exploring concordance and discordance for return of incidental findings from clinical sequencing. Genet Med (2012) 4.04
Human genome sequencing in health and disease. Annu Rev Med (2012) 3.76
Genetic diagnosis of developmental disorders in the DDD study: a scalable analysis of genome-wide research data. Lancet (2014) 3.39
Clinical application of exome sequencing in undiagnosed genetic conditions. J Med Genet (2012) 3.33
Genomics really gets personal: how exome and whole genome sequencing challenge the ethical framework of human genetics research. Am J Med Genet A (2011) 2.93
Disease gene identification strategies for exome sequencing. Eur J Hum Genet (2012) 2.89
Individualized medicine from prewomb to tomb. Cell (2014) 2.76
Unlocking Mendelian disease using exome sequencing. Genome Biol (2011) 2.62
Revisiting Mendelian disorders through exome sequencing. Hum Genet (2011) 2.57
The expanding scope of DNA sequencing. Nat Biotechnol (2012) 2.57
A timely arrival for genomic medicine. Genet Med (2011) 2.38
Computational and statistical approaches to analyzing variants identified by exome sequencing. Genome Biol (2011) 2.32
Next-generation genetic testing for retinitis pigmentosa. Hum Mutat (2012) 2.30
Solving the molecular diagnostic testing conundrum for Mendelian disorders in the era of next-generation sequencing: single-gene, gene panel, or exome/genome sequencing. Genet Med (2014) 2.08
Whole-genome sequencing for identification of Mendelian disorders in critically ill infants: a retrospective analysis of diagnostic and clinical findings. Lancet Respir Med (2015) 2.07
Molecular genetic testing and the future of clinical genomics. Nat Rev Genet (2013) 2.03
Communicating new knowledge on previously reported genetic variants. Genet Med (2012) 2.02
The promise of whole-exome sequencing in medical genetics. J Hum Genet (2013) 1.95
An international effort towards developing standards for best practices in analysis, interpretation and reporting of clinical genome sequencing results in the CLARITY Challenge. Genome Biol (2014) 1.95
Deep sequencing of patient genomes for disease diagnosis: when will it become routine? Sci Transl Med (2011) 1.91
Challenges of Big Data Analysis. Natl Sci Rev (2014) 1.79
You never call, you never write: why return of 'omic' results to research participants is both a good idea and a moral imperative. Per Med (2011) 1.75
High-throughput sequencing for biology and medicine. Mol Syst Biol (2013) 1.75
Genetic risk prediction in complex disease. Hum Mol Genet (2011) 1.65
The diagnostic approach to monogenic very early onset inflammatory bowel disease. Gastroenterology (2014) 1.63
The MedSeq Project: a randomized trial of integrating whole genome sequencing into clinical medicine. Trials (2014) 1.62
Direct-to-consumer personalized genomic testing. Hum Mol Genet (2011) 1.61
A population approach to precision medicine. Am J Prev Med (2012) 1.44
Self-guided management of exome and whole-genome sequencing results: changing the results return model. Genet Med (2013) 1.43
Applications of targeted gene capture and next-generation sequencing technologies in studies of human deafness and other genetic disabilities. Hear Res (2012) 1.43
High-throughput sequencing technologies. Mol Cell (2015) 1.42
A de novo whole gene deletion of XIAP detected by exome sequencing analysis in very early onset inflammatory bowel disease: a case report. BMC Gastroenterol (2015) 1.40
Next generation exome sequencing of paediatric inflammatory bowel disease patients identifies rare and novel variants in candidate genes. Gut (2012) 1.39
Regulatory variation in a TBX5 enhancer leads to isolated congenital heart disease. Hum Mol Genet (2012) 1.34
The coming age of data-driven medicine: translational bioinformatics' next frontier. J Am Med Inform Assoc (2012) 1.29
Analysis of DNA sequence variants detected by high-throughput sequencing. Hum Mutat (2012) 1.28
Evidence that personal genome testing enhances student learning in a course on genomics and personalized medicine. PLoS One (2013) 1.25
The genetics of complex cholestatic disorders. Gastroenterology (2013) 1.24
Drug repositioning for personalized medicine. Genome Med (2012) 1.24
Beyond gene discovery in inflammatory bowel disease: the emerging role of epigenetics. Gastroenterology (2013) 1.24
Stakeholders' opinions on the implementation of pediatric whole exome sequencing: implications for informed consent. J Genet Couns (2013) 1.21
Practices and policies of clinical exome sequencing providers: analysis and implications. Am J Med Genet A (2013) 1.21
Identifying disease mutations in genomic medicine settings: current challenges and how to accelerate progress. Genome Med (2012) 1.18
Mutations in tetratricopeptide repeat domain 7A result in a severe form of very early onset inflammatory bowel disease. Gastroenterology (2014) 1.15
Disease-causing mutations in the XIAP BIR2 domain impair NOD2-dependent immune signalling. EMBO Mol Med (2013) 1.14
Review of current methods, applications, and data management for the bioinformatics analysis of whole exome sequencing. Cancer Inform (2014) 1.13
Sequence to Medical Phenotypes: A Framework for Interpretation of Human Whole Genome DNA Sequence Data. PLoS Genet (2015) 1.12
Genetics of Inflammatory Bowel Diseases. Gastroenterology (2015) 1.11
Ethical, legal, and social implications of incorporating genomic information into electronic health records. Genet Med (2013) 1.11
Allogeneic hematopoietic cell transplantation for XIAP deficiency: an international survey reveals poor outcomes. Blood (2012) 1.11
GeneTalk: an expert exchange platform for assessing rare sequence variants in personal genomes. Bioinformatics (2012) 1.09
Explaining additional genetic variation in complex traits. Trends Genet (2014) 1.08
Genetics patients' perspectives on clinical genomic testing. Per Med (2013) 1.07
High-throughput sequencing to decipher the genetic heterogeneity of deafness. Genome Biol (2012) 1.07
Next-generation sequencing: does the next generation still have a right to an open future? Nat Rev Genet (2013) 1.06
Detection of structural DNA variation from next generation sequencing data: a review of informatic approaches. Cancer Genet (2013) 1.06
Molecular diagnostic experience of whole-exome sequencing in adult patients. Genet Med (2015) 1.06
A genome sequencing program for novel undiagnosed diseases. Genet Med (2015) 1.05
DNA sequencing: clinical applications of new DNA sequencing technologies. Circulation (2012) 1.03
X-linked inhibitor of apoptosis protein deficiency: more than an X-linked lymphoproliferative syndrome. J Clin Immunol (2015) 1.02
Exploring the utility of whole-exome sequencing as a diagnostic tool in a child with atypical episodic muscle weakness. Clin Genet (2012) 1.02
Personal genomic measurements: the opportunity for information integration. Clin Pharmacol Ther (2013) 1.01
Applications of high-throughput DNA sequencing to benign hematology. Blood (2013) 1.01
Targeted capture in evolutionary and ecological genomics. Mol Ecol (2015) 1.01
Return of genetic testing results in the era of whole-genome sequencing. Nat Rev Genet (2015) 1.00
What is complex about complex disorders? Genome Biol (2012) 1.00
Fruit flies in biomedical research. Genetics (2015) 1.00
Inflammatory Bowel Disease: Genetics, Epigenetics, and Pathogenesis. Front Immunol (2015) 0.98
Very early onset inflammatory bowel disease associated with aberrant trafficking of IL-10R1 and cure by T cell replete haploidentical bone marrow transplantation. J Clin Immunol (2014) 0.98
Design and development of exome capture sequencing for the domestic pig (Sus scrofa). BMC Genomics (2014) 0.98
Translating personalized medicine using new genetic technologies in clinical practice: the ethical issues. Per Med (2014) 0.98
Next-generation sequencing-based genome diagnostics across clinical genetics centers: implementation choices and their effects. Eur J Hum Genet (2015) 0.97
Performance comparison of SNP detection tools with illumina exome sequencing data--an assessment using both family pedigree information and sample-matched SNP array data. Nucleic Acids Res (2014) 0.97
Clinical, laboratory and molecular signs of immunodeficiency in patients with partial oculo-cutaneous albinism. Orphanet J Rare Dis (2013) 0.97
Annotating individual human genomes. Genomics (2011) 0.97
Use of Whole Genome Sequencing for Diagnosis and Discovery in the Cancer Genetics Clinic. EBioMedicine (2015) 0.97
Ethical considerations associated with clinical use of next-generation sequencing in children. J Pediatr (2011) 0.97
Teaching residents genomic pathology: a novel approach for new technology. Adv Anat Pathol (2013) 0.96
Review of massively parallel DNA sequencing technologies. Hugo J (2011) 0.96
Chapter 7: Pharmacogenomics. PLoS Comput Biol (2012) 0.96
Human genetics and genomics a decade after the release of the draft sequence of the human genome. Hum Genomics (2011) 0.95
In sickness and in health: context matters when considering potential benefits and risks of genome-wide sequencing. Genet Med (2015) 0.95
Closing the gap between knowledge and clinical application: challenges for genomic translation. PLoS Genet (2015) 0.94
Clinical analysis of genome next-generation sequencing data using the Omicia platform. Expert Rev Mol Diagn (2013) 0.93
Massively parallel sequencing: the new frontier of hematologic genomics. Blood (2013) 0.93
A community-based resource for automatic exome variant-calling and annotation in Mendelian disorders. BMC Genomics (2014) 0.93
An approach to pediatric exome and genome sequencing. Curr Opin Pediatr (2014) 0.93
'Someday it will be the norm': physician perspectives on the utility of genome sequencing for patient care in the MedSeq Project. Per Med (2015) 0.93
Genetics and disease of ventricular muscle. Cold Spring Harb Perspect Med (2014) 0.92
Exome sequencing identifies a novel FOXP3 mutation in a 2-generation family with inflammatory bowel disease. J Pediatr Gastroenterol Nutr (2014) 0.92
Whole exome sequencing in patients with white matter abnormalities. Ann Neurol (2016) 0.91
Translational bioinformatics embraces big data. Yearb Med Inform (2012) 0.91
Views of genetics health professionals on the return of genomic results. J Genet Couns (2013) 0.91
Exome Sequencing: Current and Future Perspectives. G3 (Bethesda) (2015) 0.91
Genome sequence of the Brown Norway rat yields insights into mammalian evolution. Nature (2004) 24.40
Knockout rats via embryo microinjection of zinc-finger nucleases. Science (2009) 12.33
The Collaborative Cross, a community resource for the genetic analysis of complex traits. Nat Genet (2004) 9.37
Progress and prospects in rat genetics: a community view. Nat Genet (2008) 6.01
The Rat Genome Database, update 2007--easing the path from disease to data and back again. Nucleic Acids Res (2006) 4.80
Early-onset stroke and vasculopathy associated with mutations in ADA2. N Engl J Med (2014) 4.70
Practice parameter for the diagnosis and management of primary immunodeficiency. Ann Allergy Asthma Immunol (2005) 4.44
Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity (2004) 4.11
Exploring concordance and discordance for return of incidental findings from clinical sequencing. Genet Med (2012) 4.04
The Rat Genome Database 2009: variation, ontologies and pathways. Nucleic Acids Res (2008) 3.92
A requisite role for induced regulatory T cells in tolerance based on expanding antigen receptor diversity. Immunity (2011) 3.76
Assuring the quality of next-generation sequencing in clinical laboratory practice. Nat Biotechnol (2012) 3.62
An autoinflammatory disease due to homozygous deletion of the IL1RN locus. N Engl J Med (2009) 3.56
Comparative recombination rates in the rat, mouse, and human genomes. Genome Res (2004) 3.50
A comprehensive linkage analysis for myocardial infarction and its related risk factors. Nat Genet (2002) 3.19
Efficient transgenic rat production by a lentiviral vector. Am J Physiol Heart Circ Physiol (2007) 3.07
Expression of human herpesvirus 8 in primary pulmonary hypertension. N Engl J Med (2003) 3.00
The rat genome database curators: who, what, where, why. PLoS Comput Biol (2009) 2.86
Distinct heritable patterns of angiographic coronary artery disease in families with myocardial infarction. Circulation (2005) 2.81
Selective analysis of cell-free DNA in maternal blood for evaluation of fetal trisomy. Prenat Diagn (2012) 2.79
Differential expression of granzymes A and B in human cytotoxic lymphocyte subsets and T regulatory cells. Blood (2004) 2.58
Lymphopenia in the BB rat model of type 1 diabetes is due to a mutation in a novel immune-associated nucleotide (Ian)-related gene. Genome Res (2002) 2.45
The Pharmacogenomics Research Network Translational Pharmacogenetics Program: overcoming challenges of real-world implementation. Clin Pharmacol Ther (2013) 2.39
A timely arrival for genomic medicine. Genet Med (2011) 2.38
The diagnosis and management of empyema in children: a comprehensive review from the APSA Outcomes and Clinical Trials Committee. J Pediatr Surg (2012) 2.35
Mutations in CHD7, encoding a chromatin-remodeling protein, cause idiopathic hypogonadotropic hypogonadism and Kallmann syndrome. Am J Hum Genet (2008) 2.33
Effectiveness of clinical guidelines for deep vein thrombosis prophylaxis in reducing the incidence of venous thromboembolism in critically ill children after trauma. J Trauma Acute Care Surg (2012) 2.28
Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency. Medicine (Baltimore) (2010) 2.26
Physiogenomic resources for rat models of heart, lung and blood disorders. Nat Genet (2006) 2.05
What everybody should know about the rat genome and its online resources. Nat Genet (2008) 1.94
The Rat Genome Database 2013--data, tools and users. Brief Bioinform (2013) 1.94
A scheme for defining cause of death and its application in the T cell depletion trial. Biol Blood Marrow Transplant (2007) 1.89
Identification of somatic mutations in non-small cell lung carcinomas using whole-exome sequencing. Carcinogenesis (2012) 1.84
A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry. Nat Genet (2013) 1.82
CD25 deficiency causes an immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like syndrome, and defective IL-10 expression from CD4 lymphocytes. J Allergy Clin Immunol (2006) 1.81
Development and use of active clinical decision support for preemptive pharmacogenomics. J Am Med Inform Assoc (2013) 1.80
Blockade of interleukin-6 signaling augments regulatory T-cell reconstitution and attenuates the severity of graft-versus-host disease. Blood (2009) 1.80
Diversity and dynamics of a north atlantic coastal Vibrio community. Appl Environ Microbiol (2004) 1.79
Genome-wide meta-analysis points to CTC1 and ZNF676 as genes regulating telomere homeostasis in humans. Hum Mol Genet (2012) 1.77
Long-acting injectable antiretrovirals for HIV treatment and prevention. Curr Opin HIV AIDS (2013) 1.73
Quantitative quality control in microarray experiments and the application in data filtering, normalization and false positive rate prediction. Bioinformatics (2003) 1.73
Spectrum of heart disease associated with murine and human GATA4 mutation. J Mol Cell Cardiol (2007) 1.71
Promoter polymorphisms in the nitric oxide synthase 3 gene are associated with ischemic stroke susceptibility in young black women. Stroke (2005) 1.66
Development of a routine newborn screening protocol for severe combined immunodeficiency. J Allergy Clin Immunol (2009) 1.65
Novel genetic variants contributing to left ventricular hypertrophy: the HyperGEN study. J Hypertens (2009) 1.61
Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers. Annu Rev Pharmacol Toxicol (2014) 1.58
Multiple blood pressure loci on rat chromosome 13 attenuate development of hypertension in the Dahl S hypertensive rat. Physiol Genomics (2007) 1.57
Genome-wide association analysis of blood-pressure traits in African-ancestry individuals reveals common associated genes in African and non-African populations. Am J Hum Genet (2013) 1.55
Genome sequencing reveals loci under artificial selection that underlie disease phenotypes in the laboratory rat. Cell (2013) 1.53
Genetic mapping and characterization of the bleeding disorder in the fawn-hooded hypertensive rat. Thromb Haemost (2003) 1.53
Gene targeting in NOD mouse embryos using zinc-finger nucleases. Diabetes (2013) 1.52
Randomized, double-blind, placebo-controlled trial of the efficacy and safety of rilonacept in the treatment of systemic juvenile idiopathic arthritis. Arthritis Rheumatol (2014) 1.51
Ontology searching and browsing at the Rat Genome Database. Database (Oxford) (2012) 1.51
Generation of gene-specific mutated rats using zinc-finger nucleases. Methods Mol Biol (2010) 1.51
Antibiotics and appendicitis in the pediatric population: an American Pediatric Surgical Association Outcomes and Clinical Trials Committee systematic review. J Pediatr Surg (2010) 1.50
Granulomatous-lymphocytic lung disease shortens survival in common variable immunodeficiency. J Allergy Clin Immunol (2004) 1.50
WDR11, a WD protein that interacts with transcription factor EMX1, is mutated in idiopathic hypogonadotropic hypogonadism and Kallmann syndrome. Am J Hum Genet (2010) 1.49
Dominant gain-of-function STAT1 mutations in FOXP3 wild-type immune dysregulation-polyendocrinopathy-enteropathy-X-linked-like syndrome. J Allergy Clin Immunol (2013) 1.49
Variation of BMP3 contributes to dog breed skull diversity. PLoS Genet (2012) 1.49
PG4KDS: a model for the clinical implementation of pre-emptive pharmacogenetics. Am J Med Genet C Semin Med Genet (2014) 1.49
Application of chromosomal substitution techniques in gene-function discovery. J Physiol (2004) 1.47
Identification of a molecular signature in human type 1 diabetes mellitus using serum and functional genomics. J Immunol (2008) 1.43
Analyzing complex traits with congenic strains. Mamm Genome (2010) 1.43
Laparoscopic-assisted transhiatal gastric transposition for long gap esophageal atresia in an infant. J Pediatr Surg (2010) 1.43
Beyond feasibility: a comparison of newborns undergoing thoracoscopic and open repair of congenital diaphragmatic hernias. J Pediatr Surg (2009) 1.43
Rats! Dis Model Mech (2009) 1.42
Views of nonmedical, health system professionals regarding the return of whole genome sequencing incidental findings. WMJ (2014) 1.42
Activated protein C targets CD8+ dendritic cells to reduce the mortality of endotoxemia in mice. J Clin Invest (2010) 1.41
The Rat Genome Database pathway portal. Database (Oxford) (2011) 1.40
Global study of primary immunodeficiency diseases (PI)--diagnosis, treatment, and economic impact: an updated report from the Jeffrey Modell Foundation. Immunol Res (2011) 1.40
Genomics in clinical practice: lessons from the front lines. Sci Transl Med (2013) 1.38
Pre-event smallpox vaccination and postevent exposure and disease: a report of the Joint Task Force on Smallpox Vaccination for Allergists. Ann Allergy Asthma Immunol (2005) 1.38
Chromosome substitution reveals the genetic basis of Dahl salt-sensitive hypertension and renal disease. Am J Physiol Renal Physiol (2008) 1.37
Implications of circadian gene expression in kidney, liver and the effects of fasting on pharmacogenomic studies. Pharmacogenetics (2002) 1.37
Genomic map of cardiovascular phenotypes of hypertension in female Dahl S rats. Physiol Genomics (2003) 1.37
Impact of genomics on research in the rat. Genome Res (2005) 1.37
Human gene copy number spectra analysis in congenital heart malformations. Physiol Genomics (2012) 1.30
The prevalence of digenic mutations in patients with normosmic hypogonadotropic hypogonadism and Kallmann syndrome. Fertil Steril (2011) 1.29
Target of rapamycin (TOR) signaling controls epithelial morphogenesis in the vertebrate intestine. Dev Biol (2006) 1.29
Next-generation sequencing facilitates the diagnosis in a child with twinkle mutations causing cholestatic liver failure. J Pediatr Gastroenterol Nutr (2012) 1.29
Granulomatous disease in common variable immunodeficiency. Curr Allergy Asthma Rep (2005) 1.27
Identifying multiple causative genes at a single GWAS locus. Genome Res (2013) 1.25
Use of a three-color cDNA microarray platform to measure and control support-bound probe for improved data quality and reproducibility. Nucleic Acids Res (2003) 1.25
Newborn screening for severe combined immunodeficiency; the Wisconsin experience (2008-2011). J Clin Immunol (2011) 1.25